GenSight Biologics' IPO

GenSight Biologics raised a round of funding on July 13, 2016. Investors include Public.

GenSight Biologics is a clinical-stage biotechnology company discovering and developing novel therapies for mitochondrial and neurodegenerative diseases of the eye and central nervous system. To addre…

Articles about GenSight Biologics' IPO: